ByJohn A
Questions to Ask Before Selecting Best GLP-1 Providers by State
Ask four before paying anything. Is one of your prescribers licensed in the state where I live? Which pharmacy will ship to me, and is it cleared to ship here? Will the visit be live or a questionnaire, and does that satisfy my state? What will this cost at the dose I am likely to reach by month six?
The questions that decide whether you can enroll at all
Enrollment turns on geography before it turns on anything else. Care is treated as taking place where the patient is, so the clinician needs a license in that state, and the pharmacy needs authority to dispense into it. Support staff answer these questions readily when a company is set up properly, and hedge when it is not. A reply of “we serve patients nationwide” is not an answer to either question.
The visit format question follows from the first two. States differ on what is required to establish a patient relationship remotely, and some are stricter than others about prescribing from an online questionnaire without any live interaction. Since GLP-1 medications are not controlled substances, the federal telemedicine framework built around controlled prescribing does not govern here, which leaves state medical practice rules to decide. Your state medical board publishes its own telemedicine guidance, and that is the document that settles the point rather than a customer service email.
Reading the answers
| Question | A solid answer | A weak answer |
|---|---|---|
| Who will prescribe for me? | A named clinician or medical group, licensed in your state | “One of our licensed providers”, with no name available |
| Which pharmacy fills it? | A named pharmacy you can check with your state board | “Our partner pharmacy network” |
| Is the medication compounded? | Yes or no, stated plainly, with the compounder identified | Language about “pharmaceutical grade” that avoids the word |
| What happens at higher doses? | A published price for every strength | “Pricing depends on your treatment plan” |
| What are the total recurring charges? | An itemized list including membership and visit fees | A single monthly figure with fees disclosed at checkout |
| How do I cancel? | A written procedure and a stated notice period | A promise that cancellation is easy, with no terms link |
Questions about the medication itself
Ask which molecule is prescribed and in what form. Semaglutide and tirzepatide are different drugs with different evidence behind them and different costs, and some programs start everyone on one without discussing the other. Ask whether the preparation is compounded, because compounded semaglutide and compounded tirzepatide are not FDA-approved and the agency has published concerns about unapproved GLP-1 products marketed for weight loss. That fact should come from the service before you find it elsewhere.
Ask what monitoring happens after the first month. Continued treatment is what sustains the result: trial evidence on withdrawal shows substantial weight regain after the drug stops, and maintenance studies show the benefit persists while treatment continues. A program with no plan for month twelve is selling a start rather than a course of care.
Which molecules a service stocks is worth asking early, because programs differ more than their marketing suggests. Some offer only semaglutide, others add tirzepatide, and named providers such as Ro, Hims and Hers, Henry Meds, and HealthRX each describe their own formulary and pricing for GLP-1 medications before you enroll. Manufacturer routes like LillyDirect and NovoCare carry only their single approved product, which narrows the choice but removes the sourcing question entirely.
Questions about money before the first charge
Price questions belong on the same call as licensure questions, because the answers interact. Ask for the price at each strength, whether a membership fee sits on top of medication, whether labs are included or billed separately, and whether shipping is bundled. Then ask what happens at renewal, since promotional entry rates are common across this market and frequently tied to a prepaid multi-month commitment.
Published pricing pages make this easier, and comparison hubs assembled by the platforms can help you build the question list even though they are written by interested parties. The state-level roundup published by FormBlends covers the same territory as pages from Ro, Hims and Hers, Found, and Henry Meds, and each figure taken from any of them is worth confirming on the order page before it goes into a budget. The manufacturer channels, LillyDirect for Zepbound and NovoCare for Wegovy, publish their own self-pay rates for the approved products and belong in the same spreadsheet.
Questions about continuity
Three situations break telehealth arrangements: moving, extended travel, and switching services. Ask what happens if you relocate to a state the company does not serve, whether visits are permitted while you are temporarily in another state, and how records are released if you leave. A service that will send your chart to a new clinician on request is easier to leave, which is a reason to prefer it rather than a reason to plan on leaving.
Ask also about supply gaps. Escalation schedules assume continuous availability, and a shipment delayed by two weeks at a strength change is a clinical event rather than a customer service annoyance. Whether the service ships early enough to absorb a delay is a fair thing to ask before enrolling.
Coverage questions worth one phone call
Before settling on cash pay, check whether any of it could be covered. Commercial plans differ on anti-obesity medication and commonly require prior authorization. Medicaid coverage of these drugs is a state-level decision that varies considerably, so your state agency is the only source that answers for you. Medicare drug coverage has historically excluded agents used solely for weight loss, and the CMS material on Part D sets out how that works.
Frequently asked questions
Will a service tell me its prescriber’s name before I pay?
Many will not until an account exists, though some name the medical group up front. The clinician’s name appears on the prescription and the dispensing label either way, so verification with the state medical board is always possible once treatment begins, and a refusal to name anyone at any stage is unusual.
Is an asynchronous questionnaire visit a bad sign?
Not by itself. Asynchronous care is lawful in many states and is used across telehealth. The question is whether it is lawful in yours and whether the intake collects enough clinical detail. Your state medical board’s telemedicine guidance answers the first part, and the intake form itself answers the second.
What should I ask about labs?
Whether any are required, who orders them, and who pays. Some programs bundle baseline testing, some send an order to a local draw site billed to you, and some ask for nothing. A program that skips labs is not automatically cheaper, since testing that is clinically warranted simply moves onto a different bill.
Can I ask for a different medication than the one offered?
You can ask, and the prescriber decides. Programs vary in what they stock, and some offer only one molecule. If a specific drug matters to you, confirm availability before enrolling rather than after, because switching services later means repeating intake with a new clinician.
How much should the answers to these questions weigh against price?
Enough to override a modest price difference. A cheaper program that cannot legally treat you, cannot ship to your address, or will not identify its pharmacy is not cheaper in any useful sense. Once two services both clear those questions, price becomes the reasonable tiebreaker.
